From: Effect of tranexamic acid on mortality in patients with haemoptysis: a nationwide study
Matched | ||||
---|---|---|---|---|
Control (n = 9933) | Tranexamic acid (n = 9933) | Risk difference (95% CI) | p value | |
Primary outcome | ||||
In-hospital mortality | 1141 (11.5%) | 890 (9.0%) | − 2.5 (− 3.5 to − 1.6) % | < 0.001 |
Secondary outcomes | ||||
Length of hospital stay, days | 18 ± 24 | 16 ± 18 | − 2.4 (− 3.1 to − 1.8) | < 0.001 |
Discharged to home | 8124 (81.8%) | 8410 (84.7%) | 2.9 (1.7 to 4.1%) | < 0.001 |
Total health care cost for the admission, USD | 7573 ± 10,085 | 6757 ± 9127 | − 816 (− 1109 to − 523) | < 0.001 |
Thromboembolism | 212 (2.1%) | 232 (2.3%) | 0.2 (− 0.2 to 0.6%) | 0.34 |
Seizure | 9 (0.0%) | 5 (0.0%) |